An Open Single Centre Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women on Maintenance Treatment w/Pulmicort ® Turbuhaler ® at the Dose Levels 200/400 µg Bid

NCT00228475 Phase 4 COMPLETED

The purpose to measure the concentration of budesonide in breast milk of asthmatic mothers on their normal maintenance treatment with budesonide (Pulmicort Turbuhaler), and to estimate the exposure of budesonide to infants.

Details

Lead sponsor	AstraZeneca
Phase	Phase 4
Status	COMPLETED
Enrolment	8
Start date	2004-09
Completion	2005-10

Conditions

• Asthma

Interventions

• Pulmicort (budesonide) Turbuhaler

Primary outcomes

• The concentration of budesonide in breast milk from asthmatic women
• on maintenance treatment with Pulmicort Turbuhaler

Countries

Sweden